| Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma JC Wu, YH Huang, GY Chau, CW Su, CR Lai, PC Lee, TI Huo, IJ Sheen, ... Journal of hepatology 51 (5), 890-897, 2009 | 513 | 2009 |
| Sero‐clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis T Huo, J Wu, P Lee, G Chau, W Lui, S Tsay, L Ting, F Chang, S Lee Hepatology 28 (1), 231-236, 1998 | 328 | 1998 |
| Gastrointestinal and liver manifestations in patients with COVID-19 IC Lee, TI Huo, YH Huang Journal of the Chinese Medical Association 83 (6), 521-523, 2020 | 322 | 2020 |
| Molecular pathogenesis of human hepatocellular carcinoma XW Wang, SP Hussain, TI Huo, CG Wu, M Forgues, LJ Hofseth, C Brechot, ... Toxicology 181, 43-47, 2002 | 307 | 2002 |
| Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients CW Su, YH Huang, TI Huo, HH Shih, IJ Sheen, SW Chen, PC Lee, ... Gastroenterology 130 (6), 1625-1635, 2006 | 296 | 2006 |
| Prognosis of hepatocellular carcinoma: assessment of eleven staging systems PH Liu, CY Hsu, CY Hsia, YH Lee, CW Su, YH Huang, FY Lee, HC Lin, ... Journal of hepatology 64 (3), 601-608, 2016 | 281 | 2016 |
| Evaluation of the increase in model for end-stage liver disease (ΔMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and … TI Huo, JC Wu, HC Lin, FY Lee, MC Hou, PC Lee, FY Chang, SD Lee Journal of hepatology 42 (6), 826-832, 2005 | 238 | 2005 |
| Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system CY Hsu, YH Lee, CY Hsia, YH Huang, CW Su, HC Lin, RC Lee, YY Chiou, ... Hepatology 57 (1), 112-119, 2013 | 214 | 2013 |
| Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D JC Wu, TZ Chen, TI Huo, SD Lee, KB Choo, CM Chen The Lancet 346 (8980), 939-941, 1995 | 203 | 1995 |
| Surgical resection versus radiofrequency ablation for single hepatocellular carcinoma≤ 2 cm in a propensity score model PH Liu, CY Hsu, CY Hsia, YH Lee, YH Huang, YY Chiou, HC Lin, TI Huo Annals of surgery 263 (3), 538-545, 2016 | 192 | 2016 |
| Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD mice J Chao, TI Huo, HY Cheng, JC Tsai, JW Liao, MS Lee, XM Qin, MT Hsieh, ... PloS one 9 (6), e96969, 2014 | 192 | 2014 |
| A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System CY Hsu, YH Huang, CY Hsia, CW Su, HC Lin, CC Loong, YY Chiou, ... Journal of hepatology 53 (1), 108-117, 2010 | 191 | 2010 |
| Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas HH Hung, YY Chiou, CY Hsia, CW Su, YH Chou, JH Chiang, WY Kao, ... Clinical Gastroenterology and Hepatology 9 (1), 79-86, 2011 | 186 | 2011 |
| Model for end‐stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis TI Huo, YW Wang, YY Yang, HC Lin, PC Lee, MC Hou, FY Lee, SD Lee Liver International 27 (4), 498-506, 2007 | 181 | 2007 |
| ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era PH Liu, CY Hsu, CY Hsia, YH Lee, YY Chiou, YH Huang, FY Lee, HC Lin, ... Journal of gastroenterology and hepatology 32 (4), 879-886, 2017 | 174 | 2017 |
| Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma CY Hsia, TI Huo, SY Chiang, MF Lu, CL Sun, JC Wu, PC Lee, CW Chi, ... European Journal of Surgical Oncology (EJSO) 33 (2), 208-212, 2007 | 168 | 2007 |
| External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan BL Yang, WC Wu, KC Fang, YC Wang, TI Huo, YH Huang, HI Yang, ... PloS one 10 (3), e0120443, 2015 | 147 | 2015 |
| Development and validation of a new prognostic system for patients with hepatocellular carcinoma F Farinati, A Vitale, G Spolverato, TM Pawlik, T Huo, YH Lee, AC Frigo, ... PLoS medicine 13 (4), e1002006, 2016 | 144 | 2016 |
| Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis TI Huo, XW Wang, M Forgues, CG Wu, EA Spillare, C Giannini, C Brechot, ... Oncogene 20 (28), 3620-3628, 2001 | 143 | 2001 |
| Selecting an optimal prognostic system for liver cirrhosis: the model for end‐stage liver disease and beyond TI Huo, SD Lee, HC Lin Liver International 28 (5), 606-613, 2008 | 141 | 2008 |
Shou-Dong LeeCheng Hsin General Hospital, Taipei, TaiwanOverená e-mailová adresa na: vghtpe.gov.tw